Face2Gene
#2 en IA dans la santéFdna · 4× · vu le 17 août 2026
88
Momentum
Face2Gene is an AI-powered phenotyping application by FDNA that analyzes facial images to suggest rare genetic syndromes. The platform combines deep learning image analysis with a database of thousands of disease profiles and serves clinicians as a supportive search and reference tool, not as a standalone diagnostic instrument. It is accessed via web, iOS, and Android apps and is exclusively available to verified medical professionals. For clinics and laboratories, there are also paid Enterprise product tiers (e.g., Face2Gene CLINIC, RESEARCH) with API integrations into laboratory systems.
Historique du momentum
19.05.17.08.
Fonctionnalités
| Compliance/Certification | HIPAA compliant (with BAA) and GDPR compliant; servers/data processing based in Ireland |
| Deployment Model | Cloud-based SaaS platform (private, secure cloud-based clinical data warehouse) |
| Use Case Scope | Facial phenotyping to support suspected rare genetic syndromes/developmental disorders (not a diagnostic tool) |
| Integrations | Open APIs for integration with LIMS, EMR, and variant interpretation systems |
| License | Proprietary software; use restricted exclusively to registered, verified healthcare professionals |
| Platform | Web app plus native apps for iOS (App Store) and Android (Google Play) |
| Price | Free for verified healthcare professionals (basic use); enterprise tiers with add-on costs from $40–$50 per additional case |
| Release Date | March 2014 (first product); Face2Gene RESEARCH app since March 2017 |
